Isorhapontigenin suppresses growth of patient-derived glioblastoma spheres through regulating miR-145/SOX2/cyclin D1 axis

BACKGROUND: Glioblastoma (GBM) is the most common malignant brain tumor, and glioma stem cells (GSCs) are considered a major source of treatment resistance for glioblastoma. Identifying new compounds that inhibit the growth of GSCs and understanding their underlying molecular mechanisms are therefor...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Neuro Oncol
Asıl Yazarlar: Xu, Zhou, Zeng, Xingruo, Xu, Jiawei, Xu, Derek, Li, Jingxia, Jin, Honglei, Jiang, Guosong, Han, Xiaosi, Huang, Chuanshu
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Oxford University Press 2016
Konular:
Basic and Translational Investigations
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4864260/
https://ncbi.nlm.nih.gov/pubmed/26681767
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nov298
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller